ReachMD

Dr. Scott Gottlieb is a practicing physician and resident fellow at the American Enterprise Institute, a private, nonpartisan, not-for-profit institution dedicated to research and education on issues of government, economics and social welfare. In addition, he is an internist on the hospital's inpatient medical wards at Stamford Hospital in Stamford, Connecticut.

From 2005-2007, Dr. Gottlieb served as FDA Deputy Commissioner and before that, from 2003-2004, as a senior advisor to the Food and Drug Administration's commissioner, Mark McClellan, and as the FDA's director of medical policy development. He left the FDA in the spring of 2004 to work on implementation of the new Medicare Drug Benefit as a senior adviser to the Administrator of Medicare and Medicaid Services, where he supported the agency's policy work on quality improvement and coverage and payment decision-making, particularly related to new medical technologies.

Dr. Gottlieb is the author of more than 300 articles that have appeared in leading medical journals, as well as the Wall Street Journal, the New York Times, USA Today and Forbes magazine. Dr. Gottlieb has held editorial positions on the British Medical Journal and the Journal of the American Medical Association and appears regularly as a guest commentator on the cable financial news channel CNBC.

Dr. Gottlieb completed his residency in internal medicine at Mount Sinai Hospital in New York and is a graduate of the Mount Sinai School of Medicine and of Wesleyan University, in Connecticut.